Onyx Company Profile
Background
Company Overview
Onyx is a multifaceted company operating across various industries, including technology, defense, pharmaceuticals, and energy. Each division focuses on delivering innovative solutions tailored to its respective sector.
Mission and Vision
Onyx's mission is to develop and provide cutting-edge technologies and services that address complex challenges across multiple domains. The company envisions being a leader in innovation, delivering high-quality products and services that meet the evolving needs of its diverse clientele.
Primary Areas of Focus
- Technology: Development of AI-driven enterprise solutions, including open-source platforms for enterprise search and AI assistants.
- Defense: Creation of human-machine defense technologies to enhance operational capabilities across air, land, and sea.
- Pharmaceuticals: Development and commercialization of cancer treatment medications.
- Energy: Manufacturing of building-integrated photovoltaics (BIPV) for sustainable energy solutions.
Industry Significance
Onyx's diverse operations position it as a significant player in each of its sectors, contributing to advancements in technology, defense, healthcare, and renewable energy.
Key Strategic Focus
Core Objectives
- Innovation: Continuously developing and integrating advanced technologies to maintain a competitive edge.
- Diversification: Expanding product and service offerings across multiple industries to mitigate risks and capitalize on emerging opportunities.
- Sustainability: Implementing eco-friendly practices and products, particularly in the energy sector, to promote environmental responsibility.
Specific Areas of Specialization
- AI and Machine Learning: Developing AI-driven platforms for enterprise search and assistance.
- Defense Technologies: Creating advanced systems to enhance military and law enforcement operations.
- Pharmaceuticals: Researching and producing innovative cancer therapies.
- Renewable Energy: Designing and manufacturing sustainable energy solutions, including BIPV.
Key Technologies Utilized
- Artificial Intelligence: For developing enterprise search platforms and AI assistants.
- Advanced Defense Systems: Including human-machine interfaces and modular ISR capabilities.
- Pharmaceutical Research: Utilizing cutting-edge biotechnological methods for drug development.
- Solar Energy Technologies: Incorporating photovoltaic materials into building designs.
Primary Markets Targeted
- Technology Sector: Enterprises seeking advanced AI solutions.
- Defense Sector: Military and law enforcement agencies requiring innovative defense technologies.
- Healthcare Sector: Medical institutions and patients in need of effective cancer treatments.
- Energy Sector: Construction and real estate industries interested in sustainable energy solutions.
Financials and Funding
Funding History
- Onyx (Technology Division): Raised $10 million in a seed funding round in March 2025, led by Khosla Ventures and First Round Capital.
- Onyx Pharmaceuticals: Acquired by Amgen in August 2013 for approximately $120 per share.
- Onyx Solar: Privately held; specific funding details not publicly disclosed.
Utilization of Capital
- Onyx (Technology Division): The capital is intended to support product development, market expansion, and operational scaling.
- Onyx Pharmaceuticals: The acquisition aimed to integrate Onyx's oncology portfolio into Amgen's offerings.
- Onyx Solar: Funds are likely allocated towards research and development of new photovoltaic products and expansion of manufacturing capabilities.
Pipeline Development
Onyx (Technology Division)
- Product Development: Ongoing enhancement of AI-driven enterprise search platforms and AI assistants.
- Market Expansion: Plans to extend services to new industries and geographic regions.
Onyx Pharmaceuticals
- Drug Portfolio: Focus on oncology treatments, including therapies for various cancers.
- Research Initiatives: Continued development of novel cancer therapies.
Onyx Solar
- Product Line: Development of new BIPV products integrating solar energy solutions into building materials.
- Sustainability Goals: Advancement of eco-friendly building materials to promote sustainable construction practices.
Technological Platform and Innovation
Proprietary Technologies
- Onyx (Technology Division): Open-source enterprise search and AI assistant platforms with over 40 native connectors.
- Onyx Pharmaceuticals: Innovative kinase inhibitors for cancer treatment.
- Onyx Solar: BIPV products that combine energy preservation with photovoltaic energy production.
Significant Scientific Methods
- Onyx (Technology Division): Utilizes hybrid search, advanced retrieval-augmented generation (RAG), contextual retrieval, and large language model-based knowledge graphs.
- Onyx Pharmaceuticals: Employs advanced biotechnological methods for drug discovery and development.
- Onyx Solar: Integrates photovoltaic materials into building designs to create energy-efficient structures.
Leadership Team
Onyx (Technology Division)
- Yuhong Sun: Co-Founder and CEO.
- Chris Weaver: Co-Founder and CTO.
Onyx Pharmaceuticals
- N. Anthony Coles: CEO at the time of acquisition by Amgen.
Onyx Solar
- Álvaro Beltrán: CEO.
- Teodosio del Caño: CTO & COO.